These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8801206)

  • 1. Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines.
    Bernet-Camard MF; Coconnier MH; Hudault S; Servin AL
    Gut; 1996 Feb; 38(2):248-53. PubMed ID: 8801206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.
    Bernet-Camard MF; Coconnier MH; Hudault S; Servin AL
    Infect Immun; 1996 Jun; 64(6):1918-28. PubMed ID: 8675288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells.
    Andoh A; Kinoshita K; Rosenberg I; Podolsky DK
    J Immunol; 2001 Oct; 167(7):3887-93. PubMed ID: 11564806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of human complement regulatory proteins DAF and MCP with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
    Xu L; Zhao Z; Sheng J; Zhu C; Liu H; Jiang D; Mao X; Guo M; Li W
    Biochemistry (Mosc); 2008 Sep; 73(9):1025-30. PubMed ID: 18976220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells.
    Peiffer I; Servin AL; Bernet-Camard MF
    Infect Immun; 1998 Sep; 66(9):4036-42. PubMed ID: 9712744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1992 Nov; 66(5):810-4. PubMed ID: 1384641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.
    Wang Y; Li Y; Dalle Lucca SL; Simovic M; Tsokos GC; Dalle Lucca JJ
    J Neuroinflammation; 2010 Apr; 7():24. PubMed ID: 20380727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.
    Varsano S; Kaminsky M; Kaiser M; Rashkovsky L
    Thorax; 2000 May; 55(5):364-9. PubMed ID: 10770816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Sumiyoshi K; Sakumoto H; Okabe H; Bamba T
    Immunology; 1997 Mar; 90(3):358-63. PubMed ID: 9155641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
    Pritchard MT; McMullen MR; Stavitsky AB; Cohen JI; Lin F; Edward Medof M; Nagy LE
    Gastroenterology; 2007 Mar; 132(3):1117-1126. PubMed ID: 17383432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
    Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endometria of women with endometriosis exhibit dysfunctional expression of complement regulatory proteins during the mid secretory phase.
    Palomino WA; Tayade C; Argandoña F; Devoto L; Young SL; Lessey BA
    J Reprod Immunol; 2018 Feb; 125():1-7. PubMed ID: 29153978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Sumiyoshi K; Sakumoto H; Bamba T
    Gastroenterology; 1996 Oct; 111(4):911-8. PubMed ID: 8831585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of decay-accelerating factor isoforms in the digestive tract of guinea pig.
    Mizoshita T; Joh T; Oshima T; Yamada T; Ohara H; Nomura T; Okada N; Itoh M
    Life Sci; 2002 Jan; 70(8):867-76. PubMed ID: 11853224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor.
    Zhong RK; Kozii R; Ball ED
    Br J Haematol; 1995 Oct; 91(2):269-74. PubMed ID: 8547061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells.
    Andoh A; Shimada M; Araki Y; Fujiyama Y; Bamba T
    Cancer Immunol Immunother; 2002 Feb; 50(12):663-72. PubMed ID: 11862418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
    Cheung NK; Walter EI; Smith-Mensah WH; Ratnoff WD; Tykocinski ML; Medof ME
    J Clin Invest; 1988 Apr; 81(4):1122-8. PubMed ID: 2450893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.